Evidence map›Paper›PMID 39346952›Full record

ArticleBioinformatics advances2024

SPIDER: constructing cell-type-specific protein-protein interaction networks.

Yael Kupershmidt, Simon Kasif, Roded Sharan

Abstract read
In one paragraph

Article in Bioinformatics advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Target discovery and drug design in the era of artificial intelligence.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yael KupershmidtBlavatnik School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.ORCID https://orcid.org/0009-0004-5641-2351
Simon KasifDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, United States.
Roded SharanBlavatnik School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.ORCID https://orcid.org/0000-0001-8363-4882

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Protein-protein interactions (PPIs) play essential roles in the buildup of cellular machinery and provide the skeleton for cellular signaling. However, these biochemical roles are context dependent and interactions may change across cell type, time, and space. In contrast, PPI detection assays are run in a single condition that may not even be an endogenous condition of the organism, resulting in static networks that do not reflect full cellular complexity. Thus, there is a need for computational methods to predict cell-type-specific interactions. Results: Here we present SPIDER (Supervised Protein Interaction DEtectoR), a graph attention-based model for predicting cell-type-specific PPI networks. In contrast to previous attempts at this problem, which were unsupervised in nature, our model's training is guided by experimentally measured cell-type-specific networks, enhancing its performance. We evaluate our method using experimental data of cell-type-specific networks from both humans and mice, and show that it outperforms current approaches by a large margin. We further demonstrate the ability of our method to generalize the predictions to datasets of tissues lacking prior PPI experimental data. We leverage the networks predicted by the model to facilitate the identification of tissue-specific disease genes. Availability and implementation: Our code and data are available at https://github.com/Kuper994/SPIDER.

Identifiers

PMID39346952
PMCPMC11438548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.